NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Onc.AI

Onc.AI

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://onc.ai/

Last Round

Grant

Oct 24, 2024

Total Funding Raised

$33M

Company Overview

Onc.AI is a digital health company that develops AI-driven oncology clinical management solutions using deep learning to analyze diagnostic imaging for precision cancer care.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical AI, Precision Medicine, Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

clinical decision supportmedical imaging AIoncology AInon-small cell lung cancerNSCLCimaging biomarkersimmunotherapy responseradiomicsAI diagnosticsclinical trial enrichmentpredictive oncologydigital pathologyhealth tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Onc.AI Comps

Public and private peers based on sector, stage, and business model.

Onc.AI comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Onc.AI Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 24, 2024
Series AJan 5, 2023
SeedDec 3, 2020

Key People

Founding team and executive leadership

Petr Jordan

CTO, Founding Team Member

Founding Team

Onc.AI Investors

Notable investors and investment history

Onc.AI investors
InvestorRounds
KF VenturesSeries A
National Cancer InstituteGrant
Digitalis VenturesSeed, Series A
515 VenturesSeed
Action Potential Venture CapitalSeries A
AccompliceSeries A, Seed
The Operator NetworkSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 12, 2026

    Developing AI for faster detection of rare and complex cancers.

  • May 30, 2025

    Will present deep learning radiomic biomarker results at 2025 ASCO Annual Meeting.

Onc.AI Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Onc.AI Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Onc.AI's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range27
Year Founded2020
Last FundingOct 24, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.